Specific alterations in the circulating levels of the SIRT1, TLR4, and IL7 proteins in patients with dementia
- PMID: 30071285
- DOI: 10.1016/j.exger.2018.07.018
Specific alterations in the circulating levels of the SIRT1, TLR4, and IL7 proteins in patients with dementia
Abstract
Sirtuins have gained considerable attention as epigenetic regulators for slowing aging and age-related disorders. The growing association between neurodegeneration and inflammation has led researchers to investigate interactions of sirtuins with inflammatory markers in neurodegenerative diseases. We analyzed SIRT1's association with chronic inflammation in dementia as an age-related neurodegenerative condition through Toll-like receptor 4 (TLR4) and interleukin-7 (IL7) for the first time. In the present study, we observed a significant increase in the level of SIRT1 in patients with all types of dementia. Interestingly, the level of TLR4 protein was significantly lower in only the patients with Alzheimer's disease (AD) compared to the healthy elderly subjects. There was no significant change in the level of IL7 between the diseased and healthy elderly subjects. A significant positive correlation between SIRT1 level and age in healthy elderly subjects was evident according to Pearson's correlation test. However, this correlation was not observed in the dementia patients. Furthermore, the positive correlation between the levels of IL7 and TLR4 in the healthy elderly subjects was absent in the dementia patients. However, there was no direct association between the examined single nucleotide polymorphisms (SNPs) and dementia at the molecular level. According to logistic regression analysis, dementia risk increases 1.16 times due to an increase in the SIRT1 level and 24.23 times due to a decrease in the TLR4 level. Interestingly, a high level in the total antioxidant status (TAS) increases the risk of dementia approximately 33.32 times. Therefore, the current study, for the first time, provides a much better molecular understanding of the interaction between decreasing TLR4 levels and increasing SIRT1 levels in dementia, especially in AD. Furthermore, it highlights the importance of epigenetics in several age-related diseases and suggests that developing novel therapies to prevent or slow down the progression of dementia may support healthy aging.
Keywords: Alzheimer's disease; IL-7; Oxidative stress; SIRT1 polymorphism; TLR4.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions.Front Endocrinol (Lausanne). 2018 Oct 15;9:614. doi: 10.3389/fendo.2018.00614. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30374331 Free PMC article. Review.
-
A remarkable age-related increase in SIRT1 protein expression against oxidative stress in elderly: SIRT1 gene variants and longevity in human.PLoS One. 2015 Mar 18;10(3):e0117954. doi: 10.1371/journal.pone.0117954. eCollection 2015. PLoS One. 2015. PMID: 25785999 Free PMC article. Clinical Trial.
-
Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.Neurosci Lett. 2015 Sep 25;605:44-8. doi: 10.1016/j.neulet.2015.08.012. Epub 2015 Aug 11. Neurosci Lett. 2015. PMID: 26275347
-
Sirtuin1: a promising serum protein marker for early detection of Alzheimer's disease.PLoS One. 2013 Apr 16;8(4):e61560. doi: 10.1371/journal.pone.0061560. Print 2013. PLoS One. 2013. PMID: 23613875 Free PMC article.
-
Sirtuin 1 and Alzheimer's disease: An up-to-date review.Neuropeptides. 2018 Oct;71:54-60. doi: 10.1016/j.npep.2018.07.001. Epub 2018 Jul 9. Neuropeptides. 2018. PMID: 30007474 Review.
Cited by
-
High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions.Front Endocrinol (Lausanne). 2018 Oct 15;9:614. doi: 10.3389/fendo.2018.00614. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30374331 Free PMC article. Review.
-
The Epigenetics of Alzheimer's Disease: Factors and Therapeutic Implications.Front Genet. 2018 Nov 30;9:579. doi: 10.3389/fgene.2018.00579. eCollection 2018. Front Genet. 2018. PMID: 30555513 Free PMC article. Review.
-
Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease.Cells. 2020 Oct 23;9(11):2347. doi: 10.3390/cells9112347. Cells. 2020. PMID: 33114170 Free PMC article. Review.
-
Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 Levels in Alzheimer's: The Relation Between Neuroinflammatory Pathway and Severity of Dementia.Curr Alzheimer Res. 2022;19(12):841-848. doi: 10.2174/1567205020666221226140721. Curr Alzheimer Res. 2022. PMID: 36573053
-
Prebiotics modulate the microbiota-gut-brain axis and ameliorate cognitive impairment in APP/PS1 mice.Eur J Nutr. 2023 Oct;62(7):2991-3007. doi: 10.1007/s00394-023-03208-7. Epub 2023 Jul 17. Eur J Nutr. 2023. PMID: 37460822
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical